Alina C. Boesteanu

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando et al. · Nature Medicine · 2018 · 1.7K citations · Full text

T Cell Therapy, Cancer Immunosurveillance, Chronic Lymphocytic Leukemia +6

Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide

Martha S. Jordan, Alina C. Boesteanu, Amy J. Reed et al. · Nature Immunology · 2001 · 1.6K citations

Signal Transduction, Autoimmune Disease, Lymphocyte Development +11

CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4

Sanjeev Kumar Mendiratta, William Martin, Seokmann Hong et al. · Immunity · 1997 · 593 citations · Full text

Inflammation, Promptlyproduce Il-4, Lymphocyte Development +8

Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma

Avery D. Posey, Robert D. Schwab, Alina C. Boesteanu et al. · Immunity · 2016 · 572 citations · Full text

Cancer Immunosurveillance, Oncogenic Agent, Medicine +7

Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma

Laura A. Johnson, John Scholler, Takayuki Ohkuri et al. · Science Translational Medicine · 2015 · 448 citations · Full text